000 | 01949 a2200565 4500 | ||
---|---|---|---|
005 | 20250513034546.0 | ||
264 | 0 | _c19950907 | |
008 | 199509s 0 0 eng d | ||
022 | _a0021-972X | ||
024 | 7 |
_a10.1210/jcem.80.8.7629252 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKasperk, C | |
245 | 0 | 0 |
_aHuman bone cell phenotypes differ depending on their skeletal site of origin. _h[electronic resource] |
260 |
_bThe Journal of clinical endocrinology and metabolism _cAug 1995 |
||
300 |
_a2511-7 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 |
_aAlkaline Phosphatase _xbiosynthesis |
650 | 0 | 4 | _aBlotting, Northern |
650 | 0 | 4 |
_aBone and Bones _xcytology |
650 | 0 | 4 | _aCell Division |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aDNA _xbiosynthesis |
650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xbiosynthesis |
650 | 0 | 4 |
_aFibroblasts _xcytology |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 |
_aGrowth Substances _xbiosynthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIlium |
650 | 0 | 4 |
_aInsulin-Like Growth Factor II _xbiosynthesis |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aMandible |
650 | 0 | 4 |
_aOsteoblasts _xcytology |
650 | 0 | 4 |
_aOsteocalcin _xbiosynthesis |
650 | 0 | 4 | _aOsteosarcoma |
650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
650 | 0 | 4 |
_aSkin _xcytology |
650 | 0 | 4 |
_aThymidine _xmetabolism |
650 | 0 | 4 |
_aTransforming Growth Factor beta _xbiosynthesis |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aWergedal, J | |
700 | 1 | _aStrong, D | |
700 | 1 | _aFarley, J | |
700 | 1 | _aWangerin, K | |
700 | 1 | _aGropp, H | |
700 | 1 | _aZiegler, R | |
700 | 1 | _aBaylink, D J | |
773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 80 _gno. 8 _gp. 2511-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/jcem.80.8.7629252 _zAvailable from publisher's website |
999 |
_c7628689 _d7628689 |